Female Hypoactive Sexual Desire Disorder Therapeutics Market Size And Share

Report Code : TIPRE00010487
Category : Life Sciences

No. of Pages : 150

Buy Now

تحليل حصة وحجم سوق علاجات اضطراب الرغبة الجنسية لدى الإناث بحلول عام 2031

Buy Now

Female Hypoactive Sexual Desire Disorder Therapeutics Market Report Analysis

Female Hypoactive Sexual Desire Disorder Therapeutics Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Allergan plc
AMAG Pharmaceuticals, Inc.
Emotional Brain BV
Endoceutics, Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
Palatin Technologies Inc
Pivot Pharmaceuticals Inc
Sprout Pharmaceuticals, Inc.

Regional Overview

أمريكا الشمالية
أوروبا
آسيا والمحيط الهادئ
أمريكا الجنوبية والوسطى
الشرق الأوسط وأفريقيا

Market Segmentation

By العلاج

التستوستيرون
فليبانسرين
بوسبيرون
بوبروبيون
بريميلانوتيد
العلاج السلوكي المعرفي